Kiromic BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBP and buy or sell other stocks, ETFs, and their options commission-free!About KRBP
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani, CPA
CEOPietro Bersani, CPA
Employees44
Employees44
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees44
Employees44
KRBP Key Statistics
Market cap153.33
Market cap153.33
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume367.40
Average volume367.40
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.80
52 Week high$1.80
52 Week low—
52 Week low—
Stock Snapshot
Kiromic BioPharma(KRBP) stock is priced at $0.00, giving the company a market capitalization of 153.33.
Kiromic BioPharma(KRBP) stock opened on 2026-02-04 at —. The price climbed to — and dipped to —.
The Kiromic BioPharma(KRBP)'s current trading volume is 0, compared to an average daily volume of 367.4.
People also own
Based on the portfolios of people who own KRBP. This list is generated using Robinhood data, and it’s not a recommendation.